Literature DB >> 11340368

Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients.

G Adler1, S Brassen.   

Abstract

The effects of a 5-day treatment with rivastigmine on the resting EEG power spectrum were studied in 15 mildly to moderately ill Alzheimer patients. In these patients, beta power was positively correlated with cognitive performance and negatively correlated with functional impairment. Rivastigmine produced a decrease in delta and theta power with no effect of hemisphere and electrode position. Delta power decrease reflects the cerebral cholinergic action of rivastigmine and may thus allow a quantitative assessment of its CNS effects. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11340368     DOI： 10.1159/000054902

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN： 0302-282X            Impact factor:   2.328


  12 in total

1.  Cross-conditional entropy and coherence analysis of pharmaco-EEG changes induced by alprazolam.

Authors:  J F Alonso; M A Mañanas; S Romero; M Rojas-Martínez; J Riba
Journal:  Psychopharmacology (Berl)       Date:  2011-11-30       Impact factor: 4.530

2.  Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer's disease.

Authors:  Lorena R R Gianotti; Gabriella Künig; Pascal L Faber; Dietrich Lehmann; Roberto D Pascual-Marqui; Kieko Kochi; Ursula Schreiter-Gasser
Journal:  Psychopharmacology (Berl)       Date:  2008-04-30       Impact factor: 4.530

3.  Drug effect on EEG connectivity assessed by linear and nonlinear couplings.

Authors:  Joan F Alonso; Miguel A Mañanas; Sergio Romero; Dirk Hoyer; Jordi Riba; Manel J Barbanoj
Journal:  Hum Brain Mapp       Date:  2010-03       Impact factor: 5.038

Review 4.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.

Authors:  Brianne A Kent; Stephen M Strittmatter; Haakon B Nygaard
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 6.  Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel.

Authors:  Claudio Babiloni; Xianghong Arakaki; Hamed Azami; Karim Bennys; Katarzyna Blinowska; Laura Bonanni; Ana Bujan; Maria C Carrillo; Andrzej Cichocki; Jaisalmer de Frutos-Lucas; Claudio Del Percio; Bruno Dubois; Rebecca Edelmayer; Gary Egan; Stephane Epelbaum; Javier Escudero; Alan Evans; Francesca Farina; Keith Fargo; Alberto Fernández; Raffaele Ferri; Giovanni Frisoni; Harald Hampel; Michael G Harrington; Vesna Jelic; Jaeseung Jeong; Yang Jiang; Maciej Kaminski; Voyko Kavcic; Kerry Kilborn; Sanjeev Kumar; Alice Lam; Lew Lim; Roberta Lizio; David Lopez; Susanna Lopez; Brendan Lucey; Fernando Maestú; William J McGeown; Ian McKeith; Davide Vito Moretti; Flavio Nobili; Giuseppe Noce; John Olichney; Marco Onofrj; Ricardo Osorio; Mario Parra-Rodriguez; Tarek Rajji; Petra Ritter; Andrea Soricelli; Fabrizio Stocchi; Ioannis Tarnanas; John Paul Taylor; Stefan Teipel; Federico Tucci; Mitchell Valdes-Sosa; Pedro Valdes-Sosa; Marco Weiergräber; Gorsev Yener; Bahar Guntekin
Journal:  Alzheimers Dement       Date:  2021-04-15       Impact factor: 16.655

7.  Mapping brain injury with symmetrical-channels' EEG signal analysis--a pilot study.

Authors:  Yi Li; Xiao-ping Liu; Xian-hong Ling; Jing-qi Li; Wen-wei Yang; Dan-ke Zhang; Li-hua Li; Yong Yang
Journal:  Sci Rep       Date:  2014-05-21       Impact factor: 4.379

8.  Eyes-closed task-free electroencephalography in clinical trials for Alzheimer's disease: an emerging method based upon brain dynamics.

Authors:  Elisabeth Cw van Straaten; Philip Scheltens; Alida A Gouw; Cornelis J Stam
Journal:  Alzheimers Res Ther       Date:  2014-12-19       Impact factor: 6.982

9.  Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory.

Authors:  Willem de Haan; Yolande A L Pijnenburg; Rob L M Strijers; Yolande van der Made; Wiesje M van der Flier; Philip Scheltens; Cornelis J Stam
Journal:  BMC Neurosci       Date:  2009-08-21       Impact factor: 3.288

Review 10.  Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer's disease.

Authors:  Brianne A Kent; Howard H Feldman; Haakon B Nygaard
Journal:  Prog Neurobiol       Date:  2020-08-30       Impact factor: 11.685
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.